The Domus Molecular Testing Platform
-
Highly sensitive nucleic acid testing
-
Incredibly flexible platform
-
Test a single sample for up to 10 targets
This is no ordinary RT lamp, but a one-step, one-temperature reaction highly optimized for performance in simple, inexpensive, power-free laminate device.
Respiratory Infections
​
COVID-19
Flu A / B
RSV
Strep A / B
Tuberculosis
Sexually Transmitted Infections
Chlamydia
Gonorrhea
Vector-borne diseases
Dengue
Yellow Fever
West Nile Virus
Simple 5-step process
1
Swab each nostril
for 5 seconds.
2
Insert swab and gently swirl 10 times.
3
Screw swab firmly into extraction chamber.
4
Attach chamber to card by pressing it into place.
5
Wait 30 minutes. Read the results.
What sets Domus products apart
Domus Diagnostics‘ innovative proprietary technology meets all moon-shot criteria for global population-scale infectious diseases surveillance testing​
Performance on-par with RT-PCR:
>95% sensitivity and 100% specificity*
Detects all currently circulating SARS-Cov-2 subtypes / variants
No electricity, instrumentation or skill required to get a result in approx. 30 minutes
No cold chain logistics
Storage at room temperature
NAAT Performance at the price of an Antigen test
Technology Comparison
No current technology to meet global surveillance testing moon shot criteria — until Domus Diagnostics
Global Surveillance Testing Criteria
Reliability
>95% sensitivity and 100% specificity across all virus mutations / subtypes
Time to result
< 1 hour
COGS per test
< $5
Complexity
CLIA-waived
Storage & shipping
No cold chain logistics required
Asymptomatic detection
Detection of asymptomatic / pre-symptomatic, potentially contagious cases
